Brickell Biotech is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.
Brickell Biotech is a publicly traded company on NCM using the ticker symbol VICL.
Detailed information on company financials and operating reports can be found here:
NCM: VICL
Note: Brickell Biotech's revenues are gauged from an analysis of company filings.
Investor Activity
Brickell Biotech has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
June 7, 2022
1
100%
$0 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Brickell Biotech is developing and marketing.
Brickell Biotech doesn't have any recent trademark applications, indicating Brickell Biotech is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
BRICKELL BIO Providing medical information from a web site
10/29/2021
FRESH TRACKS Providing medical information from a web site
10/29/2021
See all trademarks and details in the Full Report.
Market Share of Brickell Biotech's Largest Competitors
A competitive analysis shows these companies are in the same general field as Brickell Biotech, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Brickell Biotech.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Brickell Biotech and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.